Drug Approval | January 14, 2022
U.S. FDA approves treatment to control pain in cats with osteoarthritis
It is the first monoclonal antibody drug for use in any animal species
It is the first monoclonal antibody drug for use in any animal species
This surpasses the number of approvals supported in 2020
Health experts of the country have pointed out that the benefits of the drug outweigh the potential risks it may have in the case of high-risk patients
Dronedarone tablets USP, 400 mg have an estimated market size of US $ 500 million for twelve months ending September 2021 according to IQVIA
Simulated Moving Bed (SMB) technology is a highly engineered process for implementing chromatographic separation
Earlier last week the U.S. FDA had also shortened the time to receive a Pfizer booster shot from six months to five months for everyone 12 and older
The brand is now available pan-India through their distribution partner
Entacapone tablets USP, 200 mg have an estimated market size of US$ 10.5 million for twelve months ending September 2021, according to IQVIA
Molflu is expected to be available from early next week in pharmacies throughout the country with a particular focus on states with a high caseload of Covid-19.
Emergency Use Authorisation application request to be submitted following one month required by FDA EUA guidance
Subscribe To Our Newsletter & Stay Updated
